Morgan A.
- Country
- France
- Department
- Gastroenterology
Research Overview
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
- Comparison of mFOLFIRINOX Versus Platinum-Etoposide in First-Line Chemotherapy for Metastatic Grade 3 Gastroenteropancreatic Neuroendocrine Carcinoma
- Evaluation of Pembrolizumab Combined with XELOX and Bevacizumab in Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
Data & Insights
Has run more than one trial at 105 of 203 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment and research of colorectal cancer, with particular emphasis on stage III colon carcinoma and management of early-stage disease.
- Colon Cancer Therapeutics
- Minimal Residual Disease Detection
- Post-Surgical Treatment Strategies
Their work encompasses the evaluation of circulating tumor DNA as a biomarker for disease monitoring.
Precision Medicine
The investigator focuses on developing personalized treatment approaches using molecular diagnostic techniques to guide therapeutic decisions in gastrointestinal cancers.
- Biomarker-Driven Treatment
- Disease Recurrence Monitoring
- Treatment Response Assessment
Their research integrates advanced molecular testing with clinical decision-making.
Clinical Research
The investigator pursues innovative approaches in adjuvant therapy for gastrointestinal cancers, focusing on improving patient outcomes after surgical intervention.
- Post-Operative Care Optimization
- Treatment Efficacy Assessment
- Clinical Trial Design
Their work includes evaluation of chemotherapy effectiveness in various clinical scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.